N6-methyladenosine levels in peripheral blood RNA: a potential diagnostic biomarker for colorectal cancer
Abstract Background N6-methyladenosine (m6A) is dysregulated in various cancers, including colorectal cancer (CRC). Herein, we assess the diagnostic potential of peripheral blood (PB) m6A levels in CRC. Methods We collected PB from healthy controls (HCs) and patients with CRC, analyzed PB RNA m6A le...
Main Authors: | Chunying Zhang, Jiadi Chen, Jingyi Ren, Xiaoyu Li, Yaqin Zhang, Bihan Huang, Yihan Xu, Luyan Dong, Yingping Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-024-03289-2 |
Similar Items
-
Correction to: N6‑methyladenosine levels in peripheral blood RNA: a potential diagnostic biomarker for colorectal cancer
by: Chunying Zhang, et al.
Published: (2024-04-01) -
N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients
by: Wei Song, et al.
Published: (2021-08-01) -
Identification of a novel prognostic signature correlated with epithelial‐mesenchymal transition, N6‐methyladenosine modification, and immune infiltration in colorectal cancer
by: Xiao Qu, et al.
Published: (2023-03-01) -
Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy
by: Jiayi He, et al.
Published: (2023-04-01) -
RNA N6-methyladenosine methylation and skin diseases
by: Yaqin Yu, et al.
Published: (2023-12-01)